scispace - formally typeset
X

Xi Chen

Researcher at University of California, Davis

Publications -  629
Citations -  28889

Xi Chen is an academic researcher from University of California, Davis. The author has contributed to research in topics: Sialic acid & Medicine. The author has an hindex of 71, co-authored 548 publications receiving 22541 citations. Previous affiliations of Xi Chen include University of California, Riverside & Cleveland Clinic.

Papers
More filters
Journal ArticleDOI

Synthesis of α-Gal epitope derivatives with a galactosyltransferase–epimerase fusion enzyme

TL;DR: Nine monosaccharides and ten disacchariding were evaluated as substrates for a fusion protein, which contains both alpha-(1-->3)-galactosyltransferase and uridine-5'-diphosphogalactose 4-epimerase.
Journal ArticleDOI

A combined NMR, MD and DFT conformational analysis of 9-O-acetyl sialic acid-containing GM3 ganglioside glycan and its 9-N-acetyl mimic.

TL;DR: Results show that structural modification (O- or N-acetylation) on the C-9 of Neu5Ac in GM3 glycan does not cause significant conformational changes on either its glycosidic dihedral angles or its secondary structure.
Journal ArticleDOI

Regioselective One-Pot Multienzyme (OPME) Chemoenzymatic Strategies for Systematic Synthesis of Sialyl Core 2 Glycans.

TL;DR: This work provides a general regioselective strategy to access diverse Core 2 O-GalNAc glycans which can be extended for the synthesis of other complex branched glycans.
Journal Article

Evidence for a role of GPRC6A in prostate cancer metastasis based on case-control and in vitro analyses.

TL;DR: Findings suggest that GPRC6A is associated with aggressive PCa and may serve as a potential therapeutic target for metastatic PCa, and RUNX2, EMT and ERK signaling were shown to be up-regulated in GPRc6A overexpression cells.
Journal ArticleDOI

Effect of RhoC on the epithelial-mesenchymal transition process induced by TGF-β1 in lung adenocarcinoma cells.

TL;DR: It is demonstrated that RhoC was an essential mediator of the EMT process in lung adenocarcinoma cell line A549 which was evaluated by observing the morphological characteristics of the cells and by assessing the expression levels of two EMT marker proteins: E-cadherin and vimentin.